DocGo Inc. (DCGO) vs Edesa Biotech, Inc. (EDSA)
A side-by-side comparison of DocGo Inc. and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCGO
DocGo Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
EDSA
Edesa Biotech, Inc.
$3.87HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
Total return — DCGO vs EDSA
growth of $100 · dividends reinvested · last 6yDCGO -96.5% (-42.7%/yr)EDSA -88.8% (-30.6%/yr)EDSA compounded faster over this window
DCGO EDSA
DCGO vs EDSA: by the numbers
- •EDSA is the larger company ($37M vs $36M market cap).
- •Both run net losses; EDSA's is the smaller (0.00% vs -65.29% net margin).
Metrics side by side
Valuation
| Metric | DCGO | EDSA |
|---|---|---|
| P/S ratio | 0.12 | N/A |
| P/B ratio | 0.30 | 93.44 |
Profitability
| Metric | DCGO | EDSA |
|---|---|---|
| Gross margin | 30.12% | 0.00% |
| Operating margin | -27.67% | 0.00% |
| Net margin | -65.29% | 0.00% |
| ROE | -161.63% | -160.05% |
| ROIC | -89.44% | -166.02% |
Growth (annualized)
| Metric | DCGO | EDSA |
|---|---|---|
| Revenue CAGR (5Y) | 11.63% | N/A |
| Total return CAGR (5Y) | -48.40% | -39.88% |
Frequently asked
- How have DCGO and EDSA total returns compared?
- Over the past 5 years, DCGO delivered -48.40% and EDSA delivered -39.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.